Controlled release behaviors of chitosan/α, β- glycerophosphate thermo-sensitive hydrogels

Abstract

Chitosan/α, β-glycerophosphate (CS/α, β-GP) thermo-sensitive hydrogels presented flowable solution state at low temperature and semisolid hydrogel when the ambient temperature increased. In this research, different concentrations of metronidazole encapsulated, CS and α, β-GP, as well as different acid solvents, were chosen to evaluate their influences on the drug release behaviors from CS/α, β-GP hydrogels. It was found that there was a sustaining release during the first 3 h followed by a plateau. SEM images showed that drugs were located both on the surface and in the interior of hydrogels. The optimal preparation conditions of this hydrogel for drug release were as follows: 1.8% (w/v) CS in HAc solvent, 5.6% (w/v) α, β-GP and 5 g/L metronidazole encapsulation. Cytotoxicity evaluation found no toxic effect. In order to control the release rate, 2.5 g/L chitosan microspheres with spherical shape and smooth surface were incorporated, and it was found that the initial release process was alleviated, while drug concentration had no obvious effect on the release rate. It could be concluded that the metronidzole release behaviors could be optimized according to practical applications.

Keywords

chitosan (CS) / glycerophosphate (GP) / thermo-sensitive hydrogel / controlled release / microsphere

References

[1] The Society for Healthcare Epidemiology of America and the Infectiouslogy. Accessed March22, 2010, 9:00 am
[2] Goodman L G, Lisowski J M. Helicobacter pylori and the upper GI tract: A bug for all lesions. Hospital Formulary , 1991, 26(10): 792-800
[3] Risbud M V, Hardikar A A, Bhat S V, . pH-sensitive freeze-dried chitosan - polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. Journal of Controlled Release , 2000, 68(1): 23-30
[4] Elzatahry A A, Eldin M S M. Preparation and characterization of metronidazole-loaded chitosan nanoparticles for drug delivery application. Polymers for Advanced Technologies , 2008, 19(12): 1787-1791
[5] Chourasia M K, Jain S K. Design and development of multiparticulate system for targeted drug delivery to colon. Drug Delivery , 2004, 11(3): 201-207
[6] Bhattarai N, Gunn J, Zhang M Q. Chitosan-based hydrogels for controlled, localized drug delivery. Advanced Drug Delivery Reviews , 2010, 62(1): 83-99
[7] Chenite A, Chaput C, Wang D, . Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials , 2000, 21(21): 2155-2161
[8] Kim S, Nishimoto S K, Bumgardner J D, . A chitosan/β-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials , 2010, 31(14): 4157-4166
[9] Molinaro G, Leroux J C, Damas J, . Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials , 2002, 23(13): 2717-2722
[10] Ruel-Gariépy E, Chenite A, Chaput C, . Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. International Journal of Pharmaceutics , 2000, 203(1-2): 89-98
[11] Roughley P, Hoemann C, DesRosiers E, . The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials , 2006, 27(3): 388-396
[12] Kim S, Nishimoto S K, Bumgardner J D, . A chitosan/β-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials , 2010, 31(14): 4157-4166
[13] Kim S E, Park J H, Cho Y W, . Porous chitosan scaffold containing microspheres loaded with transforming growth factor-β1: implications for cartilage tissue engineering. Journal of Controlled Release , 2003, 91(3): 365-374
[14] Wang L M, Stegemann J P. Thermogelling chitosan and collagen composite hydrogels initiated with β-glycerophosphate for bone tissue engineering. Biomaterials , 2010, 31(14): 3976-3985
[15] Zhou H Y, Chen X G, Kong M, . Effect of molecular weight and degree of chitosan deacetylation on the preparation and characteristics of chitosan thermosensitive hydrogel as a delivery system. Carbohydrate Polymers , 2008, 73(2): 265-273
[16] Tsai M L, Chang H W, Yu H C, . Effect of chitosan characteristics and solution conditions on gelationtemperatures of chitosan/2-glycerophosphate/ nanosilver hydrogels. Carbohydrate Polymers , 2011, 84(4): 1337-1343
[17] Cho J, Heuzey M C, Bégin A, . Chitosan and glycerophosphate concentration dependence of solution behaviour and gel point using small amplitude oscillatory rheometry. Food Hydrocolloids , 2006, 20(6): 936-945
[18] Zhao Q S, Cheng X J, Ji Q X, . Effect of organic and inorganic acids on chitosan/glycerophosphate thermosensitive hydrogel. Journal of Sol–Gel Science and Technology , 2009, 50(1): 111-118
[19] Dang Q F, Yan J Q, Li J J, . Controlled gelation temperature, pore diameter and degradation of a highly porous chitosan-based hydrogel. Carbohydrate Polymers , 2011, 83(1): 171-178
[20] Crompton K E, Prankerd R J, Paganin D M, . Morphology and gelation of thermosensitive chitosan hydrogels. Biophysical Chemistry , 2005, 117(1): 47-53
[21] Crompton K E, Tomas D, Finkelstein D I, . Inflammatory response on injection of chitosan/GP to the brain. Journal of Materials Science: Materials in Medicine , 2006, 17(7): 633-639
[22] Wu J, Su Z G, Ma G H. A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. International Journal of Pharmaceutics , 2006, 315(1-2): 1-11
[23] Cho J, Heuzey M-C, Bégin A, . Physical gelation of chitosan in the presence of β-glycerophosphate: The effect of temperature. Biomacromolecules , 2005, 6(6): 3267-3275
[24] Chung Y M, Simmons K L, Gutowska A, . Sol–gel transition temperature of PLGA-g-PEG aqueous solutions. Biomacromolecules , 2002, 3(3): 511-516
[25] Kang G D, Cheon S H, Khang G, . Thermosensitive poly(organophosphazene) hydrogels for a controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics , 2006, 63(3): 340-346
[26] Patil S B, Murthy R S. Preparation and in vitro evaluation of mucoadhesive chitosan microspheres of amlodipine besylate for nasal administration. Indian Journal of Pharmaceutical Sciences , 2006, 68(1): 64-67
[27] American Society for Testing and Materials, 2000, ASTM F756-08: Standard Practice for Assessment of Hemolytic Properties of Materials
[28] Ganji F, Abdekhodaie M J, Ramazani S A A. Gelation time and degradation rate of chitosan-based injectable hydrogel. Journal of Sol–Gel Science and Technology , 2007, 42(1): 47-53